Related references
Note: Only part of the references are listed.Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure
Kinjal Desai et al.
CHILDREN-BASEL (2023)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Theresa A. McDonagh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Treatment of Hypertension: A Review
Robert M. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
Patricia Palau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
Alice M. Jackson et al.
EUROPEAN HEART JOURNAL (2021)
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Alexandros Kasiakogias et al.
JOURNAL OF HYPERTENSION (2021)
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger et al.
JOURNAL OF HYPERTENSION (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
Emmanuel Sorbets et al.
EUROPEAN HEART JOURNAL (2019)
Heart failure with preserved ejection fraction: from mechanisms to therapies
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2018)
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction
Patrick Rossignol et al.
AMERICAN JOURNAL OF HYPERTENSION (2018)
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation Vicious Twins
Dipak Kotecha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction
Nikhil Pal et al.
CIRCULATION (2015)
Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials
Jacob P. Kelly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Margaret M. Redfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer et al.
CIRCULATION (2015)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy Results of the PRAISE-2 Study (Prospective Randomized Amlodipine Survival Evaluation 2)
Milton Packer et al.
JACC-HEART FAILURE (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry
Gregg C. Fonarow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)